Senior Director, External Innovation, Ipsen
David Jenkins is currently a Senior Director in the External Innovation group at Ipsen, helping the company to grow its Oncology pipeline. Prior to Ipsen, David led the Immuno-Oncology Translational Research and Development group at TESARO, developing a large network of academic and industrial collaborators to advance therapeutic antibodies directed to PD-1, Tim-3 and LAG-3 into the clinic and provide support to earlier programs. He has also held various program leadership and R&D positions at AstraZeneca/MedImmune and Novartis with a focus on biologic/small molecule therapies and Immuno-Oncology. David received his Master’s and PhD from the University of Cambridge, U.K.